Roche

Roche (Basel, Switzerland) is a global innovative pharmaceutical and diagnostics company that uses advanced science to improve people’s lives.

Roche is one of the world’s largest developers and manufacturers of biotechnology medicines for autoimmune, haematological, infectious, neurological, neuromuscular, oncological and ophthalmological diseases.

Roche is among the leading pharmaceutical companies in terms of investment in research and development. In 2025, its R&D investment exceeded EUR 14 billion. Today’s advances in science, data processing and digital technology make it possible to understand far better the factors that affect human health and to improve treatment outcomes at every stage of the patient journey.

Roche is also a world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a leading manufacturer of diabetes self-management products. The synergy between its pharmaceutical and diagnostics divisions makes Roche a leader in personalised medicine.

Roche-Moscow JSC represents the company’s pharmaceutical division in Russia. Working with all stakeholders, the company strives to improve Russian patients’ access to innovative technologies for diagnosing and treating diseases.

20 of the company’s medicines are included in the Russian List of Vital and Essential Medicines, and more than 1.8 million patients in Russia have access to innovative Roche medicines every year.

Roche makes a long-term contribution to the development of medicine, science, public health and the pharmaceutical industry in Russia.